Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
収録刊行物
-
- The Lancet Diabetes & Endocrinology
-
The Lancet Diabetes & Endocrinology 7 (8), 618-628, 2019-08
Elsevier BV